Document is current
Any future updates will be listed below
-
Authors
Crouchet, Emilie
Bandiera, Simonetta
Fujiwara, Naoto https://orcid.org/0000-0002-4109-3421
Li, Shen
El Saghire, Hussein
Fernández-Vaquero, Mirian
Riedl, Tobias
Sun, Xiaochen
Hirschfield, Hadassa
Jühling, Frank
Zhu, Shijia https://orcid.org/0000-0002-2368-2361
Roehlen, Natascha
Ponsolles, Clara
Heydmann, Laura
Saviano, Antonio
Qian, Tongqi
Venkatesh, Anu
Lupberger, Joachim https://orcid.org/0000-0003-3996-3907
Verrier, Eloi R. https://orcid.org/0000-0002-9022-5611
Sojoodi, Mozhdeh
Oudot, Marine A.
Duong, François H. T.
Masia, Ricard
Wei, Lan
Thumann, Christine
Durand, Sarah C.
González-Motos, Victor
Heide, Danijela
Hetzer, Jenny
Nakagawa, Shigeki
Ono, Atsushi https://orcid.org/0000-0002-2482-945X
Song, Won-Min https://orcid.org/0000-0003-0948-119X
Higashi, Takaaki
Sanchez, Roberto
Kim, Rosa S.
Bian, C. Billie
Kiani, Karun
Croonenborghs, Tom
Subramanian, Aravind
Chung, Raymond T.
Straub, Beate K.
Schuppan, Detlef
Ankavay, Maliki
Cocquerel, Laurence
Schaeffer, Evelyne
Goossens, Nicolas
Koh, Anna P.
Mahajan, Milind
Nair, Venugopalan D. https://orcid.org/0000-0002-8231-6230
Gunasekaran, Ganesh
Schwartz, Myron E. https://orcid.org/0000-0002-9113-886X
Bardeesy, Nabeel https://orcid.org/0000-0003-3867-0416
Shalek, Alex K. https://orcid.org/0000-0001-5670-8778
Rozenblatt-Rosen, Orit
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Felli, Emanuele
Pessaux, Patrick
Tanabe, Kenneth K.
Heikenwälder, Mathias https://orcid.org/0000-0002-3135-2274
Schuster, Catherine https://orcid.org/0000-0001-7281-4511
Pochet, Nathalie https://orcid.org/0000-0003-1820-5656
Zeisel, Mirjam B. https://orcid.org/0000-0003-1606-0131
Fuchs, Bryan C. https://orcid.org/0000-0002-2149-3081
Hoshida, Yujin https://orcid.org/0000-0001-9430-1426
Baumert, Thomas F. https://orcid.org/0000-0002-8864-2168
- License Information
-
More Information
Article History
Received: 16 July 2020
Accepted: 3 August 2021
First Online: 17 September 2021
Competing interests
: The University of Strasbourg, Inserm, the IHU Strasbourg and Mount Sinai Hospital have filed a patent application on the clinical gene signature-based human cell culture model and uses thereof with Y.H. and T.F.B. as inventors (WO 2016174130 A1), which has been licensed to Alentis Therapeutics, Basel, Switzerland. The University of Strasbourg and Inserm have filed a patent application on H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer with E.C. and T.F.B. as inventors (PCT/EP2021/072341). A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and was an SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Neogene Therapeutics and Asimov until 31 July 2020. Since 1 August 2020, A.R. has been an employee of Genentech. O.R.R has been an employee of Genentech. T.F.B. is founder, advisor, and equity holder in Alentis Therapeutics. Y.H. and C.S. hold equity in Alentis Therapeutics. The other authors declare no competing interests.
